RxSight
RXST
RxSight (RXST) news
Recent news
RXSight: BofA global research cuts price objective to $5.50 from $6.50
AInvest Wire · Sep 22, 2026RXSight Inc: UBS cuts target price to $5.5 from $9
AInvest Wire · Jul 28, 2026RXSight - Ron Kurtz, M.D. to resign from board; Aziz Mottiwala to join board
AInvest Wire · Jul 15, 2026RXSight Inc: Not updating previously communicated financial guidance in connection with this announcement
RxSight, Inc. (NASDAQ: RXST) has announced preliminary financial results for the second quarter of 2025 and revised its full-year guidance, but has not updated previously communicated financial guidance in connection with this announcement. The company reported preliminary second-quarter revenue of…
AInvest Wire · Jul 15, 2026RxSight announces appointments of Aziz Mottiwala as chief executive officer and Ron Kurtz, M.D. as chief medical officer
AInvest Wire · Jul 15, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.